Muraki Katsuhiko, Sekine Takashi, Ando Yuna, Suzuki Hiroka, Hatano Noriyuki, Hirata Tadashi, Muraki Yukiko
Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, 1-100 Kusumoto, Chikusa, Nagoya, 464-8650, Japan.
R&D Group, Tobacco Business Headquarters, Scientific Product Assessment Center, Japan Tobacco Inc., Yokohama, 227-8512, Japan.
Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.342.
Transient receptor potential ankyrin 1 (TRPA1) is activated by noxious cold, mechanical stimulation, and irritant chemicals. In our recent study, 9, 10-phenanthrenequinone (9,10-PQ) is the most potent irritant for activation of NRF2 among 1395 cigarette smoke components and it may be, therefore, important to find its additional targets. Here, we show that 9,10-PQ functions as an activator of TRPA1 in human embryonic kidney (HEK) cells expressing human wild-type TRPA1 (HEK-wTRPA1) and human alveolar A549 (A549) cells. Application of 9,10-PQ at 0.1-10 μmol/L induced a concentration-dependent Ca response as well as inward currents at -50 mV in HEK-wTRPA1 cells. The current response was blocked by TRPA1 antagonists, HC-030031 (HC) and A-967079. To test whether 9,10-PQ affects the cysteine residues of TRPA1, we expressed mutant TRPA1 channels in HEK cells (HEK-muTRPA1) in which six different cysteine residues were replaced with serine. Among them, a mutation of cysteine 621 (C621S) abolished the 9,10-PQ-induced Ca and current responses. The channel activity induced by 9,10-PQ was also abolished in excised inside-out patches isolated from HEK-muTRPA1 cells with the C621S substitution. Although a mutation of cysteine 665 (C665S) reduced the 9,10-PQ-induced response, channel sensitization by pretreatment with Cu plus 1,10-phenanthroline and by internal dialysis of 3 μmol/L Ca restored the response. However, a double mutant with C621S and C665S substitutions had little response to 9,10-PQ, even when sensitized by Ca dialysis. In A549 cells, 9,10-PQ induced an HC-sensitive Ca response. Our findings demonstrate that 9,10-PQ activation of human TRA1 is dependent on cysteine residues 621 and 665.
瞬时受体电位锚蛋白1(TRPA1)可被有害冷刺激、机械刺激和刺激性化学物质激活。在我们最近的研究中,9,10-菲醌(9,10-PQ)是1395种香烟烟雾成分中激活NRF2最有效的刺激物,因此,找到它的其他靶点可能很重要。在这里,我们表明9,10-PQ在表达人野生型TRPA1的人胚肾(HEK)细胞(HEK-wTRPA1)和人肺泡A549(A549)细胞中作为TRPA1的激活剂发挥作用。在HEK-wTRPA1细胞中,以0.1 - 10 μmol/L的浓度应用9,10-PQ可诱导浓度依赖性的钙反应以及在-50 mV时的内向电流。电流反应被TRPA1拮抗剂HC-030031(HC)和A-967079阻断。为了测试9,10-PQ是否影响TRPA1的半胱氨酸残基,我们在HEK细胞(HEK-muTRPA1)中表达了突变型TRPA1通道,其中六个不同的半胱氨酸残基被丝氨酸取代。其中,半胱氨酸621(C621S)突变消除了9,10-PQ诱导的钙和电流反应。在从具有C621S替代的HEK-muTRPA1细胞分离的内向外膜片中,9,10-PQ诱导的通道活性也被消除。虽然半胱氨酸665(C665S)突变降低了9,10-PQ诱导的反应,但用铜加1,10-菲咯啉预处理和3 μmol/L钙的内部透析引起的通道致敏恢复了反应。然而,具有C621S和C665S替代的双突变体对9,10-PQ几乎没有反应,即使通过钙透析致敏也是如此。在A549细胞中,9,10-PQ诱导了HC敏感型钙反应。我们的研究结果表明,人TRPA1的9,10-PQ激活依赖于半胱氨酸残基621和665。